DTL
XFOR icon

Dynamic Technology Lab’s X4 Pharmaceuticals XFOR Stock Holding History

Dynamic Technology Lab’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$385K Buy
+36,221
New +$136K 0.06% 534

Other funds holding XFOR

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Dynamic Technology Lab's XFOR Position: Q1 2026 in Review

Dynamic Technology Lab opened a new position in X4 Pharmaceuticals (XFOR) in Q1 2026: 36,221 shares worth $385K. The stake represents 0.06% of the portfolio and ranks #534 among its holdings.

84 funds tracked by Wall St. Rank hold XFOR as of Q1 2026.

  • Dynamic Technology Lab held 36,221 shares of X4 Pharmaceuticals worth $385K as of Q1 2026.
  • X4 Pharmaceuticals was a new Dynamic Technology Lab position in Q1 2026.
  • X4 Pharmaceuticals made up 0.06% of Dynamic Technology Lab's portfolio in Q1 2026, its #534 holding.
  • 84 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q1 2026.

Based on Dynamic Technology Lab's 13F filing for Q1 2026, filed 15 May 2026.